阿米卡星与庆大霉素治疗尿路感染的比较。 - Suppr

Suppr

超能文献

Comparison of amikacin and gentamicin in the treatment of urinary tract infections.

作者信息

Gilbert D N, Eubanks N, Jackson J

出版信息

Am J Med. 1977 Jun;62(6):924-9. doi: 10.1016/0002-9343(77)90662-3.

DOI:10.1016/0002-9343(77)90662-3

PMID:868907

Abstract

摘要

相似文献

Comparison of amikacin and gentamicin in the treatment of urinary tract infections.

Am J Med. 1977 Jun;62(6):924-9. doi: 10.1016/0002-9343(77)90662-3.

Amikacin Therapy of Urinary tract infections.

J Infect Dis. 1976 Nov;134 SUPPL:S362-8. doi: 10.1093/infdis/135.supplement_2.s362.

Controlled comparison of amikacin and gentamicin.

N Engl J Med. 1977 Feb 17;296(7):349-53. doi: 10.1056/NEJM197702172960701.

A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.

J Antimicrob Chemother. 1983 Oct;12(4):393-402. doi: 10.1093/jac/12.4.393.

[Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].

Nihon Hinyokika Gakkai Zasshi. 1978 Mar;69(3):381-98. doi: 10.5980/jpnjurol1928.69.3_381.

Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.

Antimicrob Agents Chemother. 1978 Oct;14(4):544-8. doi: 10.1128/AAC.14.4.544.

[Clinical experience with amikacin for chronic complicated urinary tract infections in myelopathogenic bladder. Clinical effect against gentamicin-resistant bacteria (author's transl)].

Jpn J Antibiot. 1978 Jul;31(7):341-5.

[Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].

Minerva Urol. 1981 Apr-Jun;33(2):85-90.

[Serum levels in the surveillance of treatment with amikacin in urology].

Nouv Presse Med. 1979 Oct 31;8(42):3455-7.

Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.

Antimicrob Agents Chemother. 1980 Feb;17(2):217-25. doi: 10.1128/AAC.17.2.217.

引用本文的文献

Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana.

Antimicrob Resist Infect Control. 2022 Oct 3;11(1):122. doi: 10.1186/s13756-022-01160-5.

The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa.

PLoS One. 2022 Apr 25;17(4):e0267396. doi: 10.1371/journal.pone.0267396. eCollection 2022.

Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.

Infect Dis Ther. 2021 Dec;10(4):2177-2202. doi: 10.1007/s40121-021-00541-4. Epub 2021 Oct 14.

Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an Model of Intracellular Infection.

Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0146821. doi: 10.1128/AAC.01468-21. Epub 2021 Sep 27.

Glomerular filtration rate determination by creatinine and cystatin-C in patients with acute pyelonephritis.

Caspian J Intern Med. 2018 Summer;9(3):290-295. doi: 10.22088/cjim.9.3.290.

Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections.

Antimicrob Agents Chemother. 1983 Oct;24(4):494-9. doi: 10.1128/AAC.24.4.494.

[Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].

Infection. 1979;7(2):81-7. doi: 10.1007/BF01641618.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验